Related Experiment Video
Updated: Jun 22, 2026
08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Prophylactic vaccinations in chronic obstructive pulmonary disease: current status
Jay B Varkey1, Anita B Varkey, Basil Varkey
1Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA. jay.varkey@duke.edu
Current Opinion in Pulmonary Medicine
|June 18, 2009
Summary
Vaccinations, including influenza and pneumococcal vaccines, are recommended for individuals with chronic obstructive pulmonary disease (COPD) to prevent exacerbations. Addressing barriers to vaccination is crucial for improving patient and physician adherence and enhancing COPD management.
Area of Science:
- Pulmonology
- Immunology
- Infectious Diseases
Background:
- Acute exacerbations of chronic obstructive pulmonary disease (COPD) significantly contribute to global morbidity and mortality.
- Community-acquired respiratory infections are primary triggers for COPD exacerbations, necessitating preventive strategies.
- Current vaccination rates for influenza and pneumococcal disease in COPD patients fall short of public health goals.
Purpose of the Study:
- To review the role of influenza and pneumococcal vaccines in preventing COPD exacerbations.
- To discuss barriers to vaccination adherence in COPD patients and potential strategies to overcome them.
- To explore future directions in vaccine development for COPD.
Main Methods:
- Review of existing clinical trial data and epidemiological evidence on vaccine efficacy in COPD patients.
- Analysis of factors contributing to low vaccination rates.
- Discussion of potential interventions to improve vaccine uptake.
Main Results:
- Influenza vaccination demonstrates a clear benefit in reducing COPD exacerbations and may reduce hospitalizations and mortality.
- Pneumococcal vaccination reduces invasive pneumococcal disease incidence, but its impact on COPD morbidity and mortality requires further evidence.
- Combined influenza and pneumococcal vaccination may offer an additive protective effect against exacerbations.
Conclusions:
- Vaccination is a recommended preventive measure for all patients with COPD to reduce infection-related exacerbations.
- Vaccines are safe and do not cause COPD exacerbations.
- Targeted education and system-wide interventions can overcome patient and physician barriers to vaccination, while research into improved vaccines is ongoing.
Related Concept Videos
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...